Chicago, USA - 30 May `19Gut and Skin Microbiome

Official Title: The Gut and Skin Microbiome in Vitiligo Disease Progression

In Brief: Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

Ages Eligible: 18 Years to 89 Years 

Start Date: May 30, 2019

Completion Date (estimated): December 2021

Status: Active, recruiting

Study ID from ClinicalTrials.gov: NCT03577327

Location: Northwestern University, Chicago, Illinois, United States, 60611

Contact: To learn more about this study, you or your doctor may contact Prof. Caroline Le Poole, by phone +1-312-503-5944 or email NUdermatologyCTU@northwestern.edu. Please refer to this study by its NCT number.

FAQOther Questions

  • Who is prone to vitiligo?

    Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...

  • Isn't it just a cosmetic disorder?

    Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems, with multiple comorbidities. Fo...

  • Vitiligo and hearing loss: any connection?

    Vitiligo, primarily known for skin discoloration, can also affect melanocytes in the inner ear, potentially influencing hearing. Hearing loss isn't unique to vitiligo patients a...